The verdict was issued Dec. 9 in the U.S. Delaware District Court. Jurors found that four DePuy products — Zero-P VA, Zero-P, Zero-P Natural and SynFix Evolution — infringed RSB Spine’s patents. Jurors also found DePuy hadn’t proven that patent infringement claims were invalid.
The verdict concludes litigation that began with a lawsuit filed by RSB Spine Aug. 13, 2019. The lawsuit said the four DePuy products, used for spinal fusions, violated patents related to RSB Spine’s InterPlate devices.
